Home/Synchron/Dr. Thomas Oxley
DT

Dr. Thomas Oxley

Founder & CEO

Synchron

Therapeutic Areas

Synchron Pipeline

DrugIndicationPhase
Stentrode BCI SystemSevere Paralysis (e.g., from ALS, stroke, spinal cord injury)Early Feasibility Study